Literature DB >> 7363198

Verapamil and supraventricular tachyarrhythmias: beneficial effect in patients with chronic pulmonary disease.

S W Rabkin, C Tomlinson, B N Corbett, T E Cuddy.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1980        PMID： 7363198      PMCID： PMC1801604     

Source DB:  PubMed          Journal:  Can Med Assoc J        ISSN： 0008-4409            Impact factor:   8.262


× No keyword cloud information.
  14 in total

1.  Effects of intravenous verapamil on cardiac arrhythmias and on the electrocardiogram.

Authors:  M K Heng; B N Singh; A H Roche; R M Norris; C J Mercer
Journal:  Am Heart J       Date:  1975-10       Impact factor: 4.749

Review 2.  Verapamil and the myocardium.

Authors:  W G Nayler; D Krikler
Journal:  Postgrad Med J       Date:  1974-07       Impact factor: 2.401

3.  Verapamil blockade of slow Na+ and Ca++ responses in myocardial cells.

Authors:  K Shigenobu; J A Schneider; N Sperelakis
Journal:  J Pharmacol Exp Ther       Date:  1974-08       Impact factor: 4.030

4.  Action of verapamil on sinus node, atrioventricular, and intraventricular conduction.

Authors:  M H Husaini; J Kvasnicka; L Ryèn; S Holmberg
Journal:  Br Heart J       Date:  1973-07

5.  Effects of agents which inhibit the slow channel on sinus node automaticity and atrioventricular conduction in the dog.

Authors:  D P Zipes; J C Fischer
Journal:  Circ Res       Date:  1974-02       Impact factor: 17.367

6.  Asystole after verapamil.

Authors:  M E Benaim
Journal:  Br Med J       Date:  1972-04-15

7.  A fourth class of anti-dysrhythmic action? Effect of verapamil on ouabain toxicity, on atrial and ventricular intracellular potentials, and on other features of cardiac function.

Authors:  B N Singh
Journal:  Cardiovasc Res       Date:  1972-03       Impact factor: 10.787

8.  Verapamil in cardiac dysrhythmias during anaesthesia.

Authors:  G Brichard; P E Zimmermann
Journal:  Br J Anaesth       Date:  1970-11       Impact factor: 9.166

Review 9.  Electrophysiology and pharmacology of cardiac arrhythmias. VI. Cardiac effects of verapamil.

Authors:  M R Rosen; A L Wit; B F Hoffman
Journal:  Am Heart J       Date:  1975-05       Impact factor: 4.749

10.  Immediate effects of intravenous verapamil in cardiac arrhythmias.

Authors:  L Schamroth; D M Krikler; C Garrett
Journal:  Br Med J       Date:  1972-03-11
View more
  5 in total

1.  Calcium antagonists: A new class of therapeutic agents.

Authors:  Antonius Gunawan; Ali Massumi; Robert J. Hall
Journal:  Cardiovasc Dis       Date:  1981-09

2.  Management of Atrial Fibrillation: Identifying and treating the causes.

Authors:  S W Rabkin
Journal:  Can Fam Physician       Date:  1991-03       Impact factor: 3.275

Review 3.  Verapamil. An updated review of its pharmacodynamic and pharmacokinetic properties, and therapeutic use in hypertension.

Authors:  D McTavish; E M Sorkin
Journal:  Drugs       Date:  1989-07       Impact factor: 9.546

Review 4.  Calcium antagonists. Clinical use in the treatment of arrhythmias.

Authors:  B N Singh; K Nademanee; S H Baky
Journal:  Drugs       Date:  1983-02       Impact factor: 9.546

Review 5.  In The Line of Treatment: A Systematic Review of Paroxysmal Supraventricular Tachycardia.

Authors:  Farrukh Ahmad; Majdi Abu Sneineh; Ravi S Patel; Sai Rohit Reddy; Adiona Llukmani; Ayat Hashim; Dana R Haddad; Domonick K Gordon
Journal:  Cureus       Date:  2021-06-07
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.